New Born Screening

Newborn screening, also known as neonatal screening, is aimed at identifying genetic conditions and metabolic disorders in newborns shortly after birth. This can aid the child in leading a healthy, normal life. Certain inborn errors of metabolism, genetic disorders, hormone-related issues, and certain developmental problems are detected using this test. A simple blood test is done which involves collecting a few drops of blood from the baby’s heel. The blood is then sent for analysis.

At GeneAura, we recognize the importance of newborn genetic screening in early detection and intervention for optimal health outcomes in newborns.

Importance of Newborn Screening:

Newborn screening is critical for the early detection of genetic conditions and metabolic disorders that may not be apparent at birth but can have serious health consequences if left untreated. By identifying these conditions early, newborn screening enables timely intervention and medical management to prevent or minimize the risk of complications and ensure the best possible outcomes for newborns.

When to Do the Screening:

Newborn screening should be performed as soon as possible after birth, ideally within the first 24 to 48 hours of life. Early screening allows for prompt identification of any potential health issues and facilitates timely intervention and treatment if needed. Screening is recommended for newborn babies between 48 hours and 13 days old. However, screening can be performed up to the age of 2.

Newborn genetic screening tests typically screen for a panel of genetic conditions and metabolic disorders, including but not limited to: